135 related articles for article (PubMed ID: 25941336)
21. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
22. Circulating and disseminated tumor cells.
Braun S; Naume B
J Clin Oncol; 2005 Mar; 23(8):1623-6. PubMed ID: 15755968
[No Abstract] [Full Text] [Related]
23. [Study of bone marrow in patients with breast cancer to detect tumor cells and their complexes].
Sivkovych SO; Lytvynenko OO; Kaliuta OM
Lik Sprava; 2010; (5-6):100-5. PubMed ID: 21488374
[TBL] [Abstract][Full Text] [Related]
24. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
[TBL] [Abstract][Full Text] [Related]
25. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
Banys M; Solomayer EF; Becker S; Krawczyk N; Gardanis K; Staebler A; Neubauer H; Wallwiener D; Fehm T
Int J Gynecol Cancer; 2009 Jul; 19(5):948-52. PubMed ID: 19574790
[TBL] [Abstract][Full Text] [Related]
26. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow.
Schlimok G; Riethmüller G
Semin Cancer Biol; 1990 Jun; 1(3):207-15. PubMed ID: 2103496
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of tumor cells in the bone marrow.
Mendoza CB; Moore GE; Crosswhite LH; Sandberg AA; Watne AL
Surg Gynecol Obstet; 1969 Sep; 129(3):483-8. PubMed ID: 5820928
[No Abstract] [Full Text] [Related]
28. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
[TBL] [Abstract][Full Text] [Related]
29. Circulating cancer cells in peripheral blood. A case report.
Rodríguez-Salas N; Jiménez-Gordo AM; González E; de las Heras B; Zamora P; Espinosa E; Fernández de Castro M; González-Barón M
Acta Cytol; 2000; 44(2):237-41. PubMed ID: 10740613
[TBL] [Abstract][Full Text] [Related]
30. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of the detection of circulating tumor cells in breast cancer patients.
Banys M; Hartkopf AD; Krawczyk N; Becker S; Fehm T
Biomark Med; 2012 Feb; 6(1):109-18. PubMed ID: 22296204
[TBL] [Abstract][Full Text] [Related]
32. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
[TBL] [Abstract][Full Text] [Related]
33. HER2-positive DTCs/CTCs in breast cancer.
Hartkopf AD; Banys M; Fehm T
Recent Results Cancer Res; 2012; 195():203-15. PubMed ID: 22527508
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and clinical significance of disseminated tumor cells in bone marrow].
Braun S; Pantel K
Dtsch Med Wochenschr; 2000 Oct; 125(41):1237-9. PubMed ID: 11076263
[No Abstract] [Full Text] [Related]
35. Journey to a faraway land.
Alkan A; Karcı E; Utkan G
Ann Oncol; 2015 Oct; 26(10):2200. PubMed ID: 26205394
[No Abstract] [Full Text] [Related]
36. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
Klein CA
Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
[TBL] [Abstract][Full Text] [Related]
37. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Demeulemeester J; Kumar P; Møller EK; Nord S; Wedge DC; Peterson A; Mathiesen RR; Fjelldal R; Zamani Esteki M; Theunis K; Fernandez Gallardo E; Grundstad AJ; Borgen E; Baumbusch LO; Børresen-Dale AL; White KP; Kristensen VN; Van Loo P; Voet T; Naume B
Genome Biol; 2016 Dec; 17(1):250. PubMed ID: 27931250
[TBL] [Abstract][Full Text] [Related]
38. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Boudou E; Pouillart P; Thiery JP; de Cremoux P
Int J Cancer; 2005 Mar; 114(2):291-8. PubMed ID: 15543615
[TBL] [Abstract][Full Text] [Related]
39. Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.
Barok M; Balázs M; Nagy P; Rákosy Z; Treszl A; Tóth E; Juhász I; Park JW; Isola J; Vereb G; Szöllosi J
Cancer Lett; 2008 Feb; 260(1-2):198-208. PubMed ID: 18096313
[TBL] [Abstract][Full Text] [Related]
40. Reply to the letter to the editor 'Journey to a faraway land' by Alkan et al.
Hartkopf AD; Brucker SY; Taran FA
Ann Oncol; 2015 Oct; 26(10):2200-1. PubMed ID: 26209641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
